Skip to main content

Published locations for ‘Promising’ durvalumab results spark phase 3 trial in mesothelioma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ‘Promising’ durvalumab results spark phase 3 trial in mesothelioma

User login

  • Reset your password
  • /content/promising-durvalumab-results-spark-phase-3-trial-mesothelioma
  • /fedprac/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial-mesothelioma
  • /internalmedicinenews/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial
  • /oncologypractice/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial
  • /fedprac/avaho/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial
  • /hematology-oncology/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial
  • /internalmedicine/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial
  • /chestphysician/article/223312/lung-cancer/promising-durvalumab-results-spark-phase-3-trial